⚡️ What’s new in healthcare this week?
A curated list of every week's most relevant links on Digital Health News, hand-picked for you by Light-it.
Inito makes at-home diagnostic devices, starting with a fertility monitor that tracks hormones through a smartphone-connected reader. The device measures multiple hormones from a single test strip to give users clearer ovulation insights. The company is also developing additional tests that follow the same at-home, lab-style format. Its goal is to make accurate hormone and health tracking easier for anyone to do at home.
Hey there, Insider!
👋🏼 Hope your week’s been kind. We’re sliding back into your Friday with the digital health updates you actually want to read. Scouts honor.
Let’s jump into what’s worth your time 👇🏼
Epic connects 17 healthcare organizations to federal health information network.
Change cyberattack relief funding overpaid many hospitals: study.
Hims & Hers launches weight loss program and Hers Platform in the UK.
Sleep.ai launches Sleep Sense: turn any smartphone into a precision sleep tracker.
Tether rolls out privacy-focused health app as expansion into AI accelerates.
AI-focused deals now make up 75% of health tech funding, J.P. Morgan report finds.
Adoption of artificial intelligence in the healthcare sector.
Jan. 6-9, 2026 | Las Vegas, NV
CES®
Until next week, stay connected!
Digital Health Insider.











Really solid curation here. The Hims & Hers UK move is smart timing given how NHS wait times for specialist care keep pushing people toward private solutions. Telehealth companes scaling internationally always face the regulatory friction question tho, and I'm curious if they'll adapt their DTC model or partner locally. I've watched similar US healthtech players stumble on reimbursment dynamics abroad.